Lung Cancer Trial, Recruiting NCT05999214 Sponsor: First Affiliated Hospital Xi'an Jiaotong University Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT05999214
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old
  • People diagnosed with non-small cell lung cancer (a type of lung cancer), confirmed by a tissue or cell sample, where surgery to remove the cancer is not possible due to the cancer returning, spreading, or the person's overall health
  • People who have already completed 2 to 4 rounds of first-line (initial) cancer treatment — such as chemotherapy, immunotherapy, or combinations of these — and whose cancer was assessed as stable (not growing or shrinking significantly) during that treatment
  • People who have at least one tumour that can be measured on scans
  • People who have not had radiotherapy to any tumour site in the 28 days before joining the trial
  • People with a physical functioning score of 0–2 on a standard medical scale (meaning able to carry out at least some daily activities) (confirm with trial site)
  • People whose life expectancy is estimated to be at least 3 months
  • People who are willing to take part and have signed a consent form

Who may not be able to join:

  • Women who are pregnant, breastfeeding, or planning to become pregnant within 6 months
  • People with severe cancer spread to the brain or bones
  • People with severe anaemia (very low red blood cell levels) or severe liver or kidney damage
  • People whose pathology results or long-term follow-up records may not be available
  • People whose relevant scan images and clinical records are not available
  • People with serious illnesses that would make participation difficult, such as a recent major heart or stroke event, or other serious heart conditions
  • People who have had surgery or any invasive procedure within 4 weeks before joining the trial
  • People who are unable to tolerate standard second-line cancer treatment or other first-line therapies
  • People with a known allergy to the study imaging agent (99mTc-H7ND) or any of its ingredients, or who have a history of severe allergic reactions
  • People for whom the imaging procedures used in the trial are not medically suitable (confirm with trial site)
  • People whom the trial investigator considers unsuitable for participation for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rui Gao, First Affiliated Hospital Xi'an Jiaotong University

Phone: 0086-13772488039

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Registry
ClinicalTrials.gov
Start date
13 September 2023
Est. completion
10 August 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

DCR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov